Related Experiment Video
Updated: Jun 25, 2026
04:44
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
The future of occupationally related diffuse lung disease
Amy M Nuernberg1, David C Christiani
1Department of Environmental Health, Harvard School of Public Health, Boston, Massachusetts 02115, USA.
Seminars in Respiratory and Critical Care Medicine
|February 18, 2009
Summary
New occupational lung diseases are emerging, with research focusing on genetic factors and biomarkers. Understanding genetic predispositions can identify high-risk populations, but preventing airborne exposure remains key.
Area of Science:
- Occupational medicine
- Environmental health
- Genetics
Background:
- Several new occupational lung diseases have been identified in the past decade.
- Advances in exposure measurement have led to the adoption of molecular epidemiology and genomics.
- There is a growing body of research on genetic associations and biomarkers for occupationally related diffuse lung diseases.
Purpose of the Study:
- To investigate genetic polymorphisms that contribute to population-attributable risk of occupational lung diseases.
- To explore the role of gene-environment interactions in the development of these diseases.
- To identify specific populations at higher risk following occupational exposure.
Main Methods:
- Utilizing candidate gene approaches.
- Employing genome-wide association studies (GWAS) for gene-environment interaction analysis.
- Analyzing genetic polymorphisms and their association with diffuse lung diseases.
Main Results:
- Focus on common variant genetic polymorphisms with low penetrance but high population-attributable risk.
- Genome-wide association studies are becoming more feasible for gene-environment interaction research.
- Studies aim to define high-risk populations post-exposure.
Conclusions:
- Genetic studies can help identify individuals at increased risk for occupational lung diseases.
- The primary strategy for preventing these diseases remains the control of airborne exposures.
- Future research will refine risk assessment through genetic and environmental factor analysis.
Related Concept Videos
01:20COPD: Pathogenesis and Clinical Features
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:26COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
01:29Chronic Obstructive Pulmonary Disease-V: Management
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...